Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve To consider and approve ....

J O H N S O N PHARMACARE LIMITED CIN: L51100GJ1994PLC022388 Registered Office Address - Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium , Navrangpura, Ahmedabad City, Gujarat, India, 380009 Email id:sunandshineworldwideltd@gmail.com Date: 08.08.2026 The Department of Corporate Service BSE Limited PhirozeJeejeebhoy Towers, Dalal Street, Mumbai – 400001. SCRIP CODE: 532154 (JOHNSON PHARMACARE LTD) EQ - ISIN - INE560F01022 Dear Sir/Madam, Subject: Prior Intimation of Board Meeting for Approval of Un-Audited (Standalone) Financial Results for the Quarter ended on 30th June, 2026. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 we hereby inform you that a meeting of Board of Directors of the Company will be held on Thursday 13th August, at the registered office of the Company at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad City, Gujarat- 380009 with respect to following: 1. To consider and approve the Un-Audited (Standalone) Financial Results of the Company for the Quarter ended on 30th June, 2026. This is also to inform that the Trading Window of the Company has been closed from 01st July, 2026 and will remain closed till the completion of 48 hours after the declaration of unaudited (Standalone) Financial Results of the Company for the quarter ended on 30th June, 2026. 2. Any other agenda, with prior permission of Chairperson. This is for your information and record. Thanking You For and on behalf of Board of Directors JOHNSON PHARMACARE LIMITED Nand Kishor Ray Additional Director DIN: 11626638 Page 1 of 1